Hormone Treatment Reduces Breast Cancer Risk in Mice
Author Information
Author(s): Rajkumar Lakshmanaswamy, Kittrell Frances S, Guzman Raphael C, Brown Powel H, Nandi Satyabrata, Medina Daniel
Primary Institution: Texas Tech University Health Sciences Center
Hypothesis
Can short-term hormone treatment prevent mammary tumorigenesis in genetically engineered mouse models?
Conclusion
Short-term hormone treatment with estrogen and progesterone significantly reduces the incidence of mammary tumors in mouse models.
Supporting Evidence
- A 2-week exposure to hormones decreased tumor incidence by 70 to 88% in one model.
- Hormone treatment reduced tumor multiplicity by 91% in another model.
- Short-term hormone exposure delayed tumor development significantly.
- Both hormone-treated models showed reduced proliferation activity.
Takeaway
Giving mice hormones for a short time can help stop them from getting breast cancer.
Methodology
Mice were treated with estrogen and progesterone for 2 to 3 weeks and monitored for tumor development.
Limitations
The study was conducted in mouse models, which may not fully replicate human breast cancer.
Participant Demographics
Genetically engineered mouse models, including p53-null and activated Her-2/neu mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website